Clinical Trials Browser

Phase 3 × zilucoplan × 90 days × Clear all

NCT06435312 2026-03-13

ziMyG+

Phase 3 Enrolling by invitation

Myasthenia Gravis

NCT07215949 2026-02-23

Zilucoplan for Severe gMG Exacerbations

Phase 3 Recruiting

Myasthenia Gravis